Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling

Oncogene volume 19, pages 5419–5427 (2000)Cite this article

Abstract

While the activated viral Src oncoprotein, v-Src, induces uncontrolled cell growth, the mechanisms underlying cell cycle deregulation by v-Src have not been fully defined. Previous studies demonstrated that v-Src induces constitutively active STAT3 signaling that is required for cell transformation and recent data have implicated STAT3 in the transcriptional control of critical cell cycle regulators. Here we show in mouse fibroblasts stably transformed by v-Src that mRNA and protein levels of p21 (WAF1/CIP1), cyclin D1, and cyclin E are elevated. Using reporter constructs in transient-transfection assays, the cyclin D1 and p21 promoters were both found to be transcriptionaly induced by v-Src in a STAT3-dependent manner. The kinase activities of cyclin D/CDK4, 6 and cyclin E/CDK2 complexes were only slightly elevated, consistent with the findings that coordinate increases in p21, cyclin D1 and cyclin E resulted in an increase in cyclin/CDK/p21 complexes. Similar results were obtained in NIH3T3 and BALB/c 3T3 cells stably transformed by v-Src, indicating that these regulatory events associated with STAT3 signaling represent common mechanisms independent of cell line or clonal variation. These findings suggest that STAT3 has an essential role in the regulation of critical cell cycle components in v-Src transformed mouse fibroblasts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Akira S. . 1999 Stem Cells 17: 138–146.

  • Barboule N, Baldin V, Jozan S, Vidal S and Valette A. . 1998 Int. J. Cancer 76: 891–896.

  • Bellido T, O'Brien CA, Roberson PK and Manolagas SC. . 1998 J. Biol. Chem. 273: 21137–21144.

  • Besser D, Bromberg JF, Darnell Jr JE and Hanafusa H. . 1999 Mol. Cell. Biol. 19: 1401–1409.

  • Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A and Jansen-Durr P. . 1996 Mol. Cell. Biol. 16: 3401–3409.

  • Bowman T, Garcia R, Turkson J and Jove R. . 2000 Oncogene 19: 2474–2488.

  • Bromberg JF and Darnell Jr JE. . 2000 Oncogene 19: 2468–2473.

  • Bromberg JF, Fan Z, Brown C, Mendelsohn J and Darnell Jr JE. . 1998a Cell Growth Differ. 9: 505–512.

  • Bromberg JF, Horvath CM, Besser D, Lathem WW and Darnell Jr JE. . 1998b Mol. Cell. Biol. 18: 2553–2558.

  • Bromberg JF, Horvath CM, Wen Z, Schreiber RD and Darnell Jr JE. . 1996 Proc. Natl. Acad. Sci. USA 93: 7673–7678.

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE. . 1999 Cell 98: 295–303.

  • Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L and de Groot RP. . 1996 J. Biol. Chem. 271: 13221–13227.

  • Cao X, Tay A, Guy GR and Tan YH. . 1996 Mol. Cell. Biol. 16: 1595–1603.

  • Carlesso N, Frank DA and Griffin JD. . 1996 J. Exp. Med. 183: 811–820.

  • Carnero A and Hannon GJ. . 1998 Curr. Top. Microbiol. Immunol. 227: 43–55.

  • Catlett-Falcone R, Dalton W and Jove R. . 1999a Current Opinion Oncology 11: 490–496.

  • Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R. . 1999b Immunity 10: 105–115.

  • Chai SK, Nichols GL and Rothman P. . 1997 J. Immunol. 159: 4720–4728.

  • Chaturvedi P, Sharma S and Reddy EP. . 1997 Mol. Cell Biol. 17: 3295–3304.

  • Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM and Sherr CJ. . 1999 EMBO J. 18: 1571–1583.

  • Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y and Fu XY. . 1996 Science 272: 719–722.

  • Chomczynski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.

  • Danial NN, Pernis A and Rothman PB. . 1995 Science 269: 1875–1877.

  • Darnell Jr JE. . 1997 Science 277: 1630–1635.

  • Darnell Jr JE, Kerr, IM and Stark GR. . 1994 Science 264: 1415–1421.

  • Dyson N. . 1998 Genes Dev. 12: 2245–2262.

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, Bartek J and Bosch FX. . 1997 Int. J. Cancer 74: 383–389.

  • Florenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM and Kerbel RS. . 1999 Oncogene 18: 1023–1032.

  • Frank DA. . 1999 Molecular Med. 5: 432–456.

  • Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K and Hirano T. . 1996 Immunity 5: 449–460.

  • Garcia R and Jove R. . 1998 J. Biomed. Sci. 5: 79–85.

  • Garcia R, Yu C-L, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP and Jove R. . 1997 Cell Growth. Differ. 8: 1267–1276.

  • Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C and Weinberg RA. . 1996 Oncogene 12: 1173–1180.

  • Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L. . 1996 Blood 87: 1692–1697.

  • Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy DJ. . 1998 J. Clin. Invest. 102: 1385–1392.

  • Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L and Swindell E . 1995 Mol. Biol. Cell. 6: 387–400.

  • Hauser PJ, Agrawal D, Hackney J and Pledger WJ. . 1998 Cell Growth Differ. 9: 847–855.

  • Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, Clayton RN and Farrell WE. . 1999 Clin. Cancer Res. 5: 2133–2139.

  • Hiyama H, Iavarone A, LaBaer J and Reeves SA. . 1997 Oncogene 14: 2533–2542.

  • Johnson D, Frame MC and Wyke JA. . 1998a Oncogene 16: 2017–2028.

  • Johnson MR, Valentine C, Basilico C and Mansukhani A. . 1998b Oncogene 16: 2647–2656.

  • Jove R and Hanafusa H. . 1987 Annu. Rev. Cell Biol. 3: 31–56.

  • Karni R, Jove R and Levitzki A. . 1999 Oncogene 18: 4654–4662.

  • Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL and Robertson JF. . 1999 Clin. Cancer Res. 5: 2069–2076.

  • LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E. . 1997 Genes Dev. 11: 847–862.

  • Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Wantanabe G, Haines GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ and Pestell RG. . 2000 Mol. Cell. Biol. 20: 672–683.

  • Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GKR, Webster M, Muller WJ, Brugge JS, Davis RJ and Pestell RG. . 1999 J. Biol. Chem. 274: 7341–7350.

  • Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, Kang WK, Wang XF, Kim SJ and Trepel JB. . 1998 J. Biol. Chem. 273: 10618–10623.

  • Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ and Yang-Yen HF. . 1995 Mol. Cell. Biol. 15: 3654–3663.

  • Lonardo F, Rusch V, Langenfeld J, Dmitrovsky E and Klimstra DS. . 1999 Cancer Res. 59: 2470–2476.

  • Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y and Kanakura Y. . 1997 Mol. Cell. Biol. 17: 2933–2943.

  • Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG and Kanakura Y. . 1999 EMBO J. 18: 1367–1377.

  • Nevins JR. . 1998 Cell Growth Differ. 9: 585–593.

  • Ohtani K, DeGregori J and Nevins JR. . 1995 Proc. Natl. Acad. Sci. USA 92: 12146–12150.

  • Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J. . 1994 Cell 78: 59–66.

  • Qin LF, Ng IO, Fan ST and Ng M. . 1998 Int. J. Cancer 79: 424–428.

  • Schindler C and Darnell Jr JE. . 1995 Annu. Rev. Biochem. 64: 621–651.

  • Seidel HM, Milocco LH, Lamb P, Darnell JEJ, Stein RB and Rosen J. . 1995 Proc. Natl. Acad. Sci. USA 92: 3041–3045.

  • Sherr CJ. . 1993 Cell 73: 1059–1065.

  • Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.

  • Sherr CJ and Roberts JM. . 1999 Genes Dev. 13: 1501–1512.

  • Shimizu M, Nikaido T, Toki T, Shiozawa T and Fujii S. . 1999 Cancer 85: 669–677.

  • Toyoshima H and Hunter T. . 1994 Cell 78: 67–74.

  • Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S and Jove R. . 1999 Mol. Cell. Biol. 19: 7519–7528.

  • Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP and Jove R. . 1998 Mol. Cell. Biol. 18: 2545–2552.

  • Wen X, Lin HH, Shih HM, Kung HJ and Ann DK. . 1999 J. Biol. Chem. 31: 38204–38210.

  • Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R and Finke J. . 1996 Blood 88: 809–816.

  • Winston J, Dong F and Pledger WJ. . 1996 J. Biol. Chem. 271: 11253–11260.

  • Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R. . 1995 Science 269: 81–83.

  • Zhong Z, Wen Z and Darnell Jr JE. . 1994 Science 264: 95–98.

  • Zong CS, Zeng L, Jiang Y, Sadowski HB and Wang LH. . 1998 J. Biol. Chem. 273: 28065–28072.

Download references

Acknowledgements

We thank members of the laboratory for stimulating discussions, E Leof for antibodies, B Vogelstein and G Peters for promoter constructs, N Olashaw for helpful comments on the manuscript, and Moffitt Cancer Center's Molecular Biology, Flow Cytometry and Molecular Imaging Core Facilties for assistance. This work was supported by NIH grants CA55652 and CA67360, and by the Cortner-Couch Endowed Chair for Cancer Research (to WJ Pledger).

Author information

Authors and Affiliations

  1. Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, 33612, Florida FL, USA

    Dominic Sinibaldi, Walker Wharton, James Turkson, Tammy Bowman, Warren J Pledger & Richard Jove

  2. Department of Oncology, University of South Florida College of Medicine, Tampa, 33612, Florida FL, USA

    Dominic Sinibaldi, James Turkson, Tammy Bowman, Warren J Pledger & Richard Jove

  3. Department of Biochemistry and Molecular Biology, University of South Florida College of Medicine, Tampa, 33612, Florida FL, USA

    Dominic Sinibaldi, Warren J Pledger & Richard Jove

  4. Department of Pathology, University of South Florida College of Medicine, Tampa, 33612, Florida FL, USA

    Walker Wharton & Richard Jove

Authors
  1. Dominic Sinibaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walker Wharton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Turkson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tammy Bowman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Warren J Pledger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Richard Jove
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sinibaldi, D., Wharton, W., Turkson, J. et al. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19, 5419–5427 (2000). https://doi.org/10.1038/sj.onc.1203947

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203947

Keywords

This article is cited by

Search

Advanced search

Quick links